Fact CheckerSign in

NCT05774561Recruiting

Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

Liquid Biopsies - a Possible Tool for Treatment Monitoring and Early Recurrence Detection in HPV-associated Diseases

Source: ClinicalTrials.gov · Last updated 12 Feb 2026

Brief summary (registry, in English)

This trial will evaluate the possible benefits and the performance of liquid biopsies in HPV-associated cancer treatment monitoring. This study aims to find a combination of an adequately sensitive and specific sampling method and biomarkers for early risk stratification of disease recurrence.

Status (registry)
Recruiting
Study type
Observational
Enrollment
480 (estimated)
First submitted
24 Jan 2023
Start date
1 Jun 2022
Primary completion date
31 May 2026
Lead sponsor
The Institute of Molecular and Translational Medicine, Czech Republic
NCT number
NCT05774561

What you commit to

  • Study type: Observational
  • Planned participants: 480
  • From 1 Jun 2022 to the primary completion date, 31 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • No exclusion criteria are set.

Who the study is looking for

  • Women diagnosed with CC/HSIL. Men and women diagnosed with OPC. Patients must agree with study enrollment and must sign study informed consent.

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital Olomouc
Coordinator of this site? Confirm its status		OlomoucCzechiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.